| ［1］ |
Graves N, Phillips CJ, Harding K. A narrative review of the epidemiology and economics of chronic wounds［J］. Br J Dermatol, 2022,187（2）:141⁃148. DOI: 10.1111/bjd.20692.
|
| ［2］ |
Balasubramani M, Kumar TR, Babu M. Skin substitutes: a review［J］. Burns, 2001,27（5）:534⁃544. DOI: 10.1016/s0305⁃4179（01）00018⁃3.
|
| ［3］ |
Schmiedova I, Dembickaja A, Kiselakova L, et al. Using of amniotic membrane derivatives for the treatment of chronic wounds［J］. Membranes （Basel）, 2021,11（12）:941. DOI: 10.3390/ membranes11120941.
|
| ［4］ |
Ontario Health （Quality）. Skin substitutes for adults with diabetic foot ulcers and venous leg ulcers: a health technology assessment［J］. Ont Health Technol Assess Ser, 2021,21（7）:1⁃165.
|
| ［5］ |
Li Y, An S, Deng C, et al. Human acellular amniotic membrane as skin substitute and biological scaffold: a review of its preparation, preclinical research, and clinical application［J］. Pharmaceutics, 2023,15（9）:2249. DOI: 10.3390/pharmaceutics 15092249.
|
| ［6］ |
Hashemi SS, Mohammadi AA, Moshirabadi K, et al. Effect of dermal fibroblasts and mesenchymal stem cells seeded on an amniotic membrane scaffold in skin regeneration: a case series［J］. J Cosmet Dermatol, 2021,20（12）:4040⁃4047. DOI: 10.1111/jocd.14043.
|
| ［7］ |
Xiao S, Xiao C, Miao Y, et al. Human acellular amniotic membrane incorporating exosomes from adipose⁃derived mesenchymal stem cells promotes diabetic wound healing［J］. Stem Cell Res Ther, 2021,12（1）:255. DOI: 10.1186/s13287⁃021⁃02333⁃6.
|
| ［8］ |
Lotfi Z, Khakbiz M, Davari N, et al. Fabrication and multiscale modeling of polycaprolactone/amniotic membrane electrospun nanofiber scaffolds for wound healing［J］. Artif Organs, 2023,47（8）:1267⁃1284. DOI: 10.1111/aor.14518.
|
| ［9］ |
Álvaro⁃Afonso FJ, García⁃Álvarez Y, Lázaro⁃Martínez JL, et al. Advances in dermoepidermal skin substitutes for diabetic foot ulcers［J］. Curr Vasc Pharmacol, 2020,18（2）:182⁃192. DOI: 10.2174/1570161117666190408170144.
|
| ［10］ |
Tognetti L, Pianigiani E, Ierardi F, et al. The use of human acellular dermal matrices in advanced wound healing and surgical procedures: state of the art［J］. Dermatol Ther, 2021,34（4）:e14987. DOI: 10.1111/dth.14987.
|
| ［11］ |
Boháč M, Danišovič Ľ, Koller J, et al. What happens to an acellular dermal matrix after implantation in the human body? a histological and electron microscopic study［J］. Eur J Histochem, 2018,62（1）:2873. DOI: 10.4081/ejh.2018.2873.
|
| ［12］ |
Gormley S, Hart O, French S, et al. The use of fetal bovine acellular dermal matrix in severe diabetic foot ulceration and threatened limbs with tissue loss the use of FBADM as an adjunct for complex wounds［J］. Vascular, 2024,32（3）:619⁃625. DOI: 10.1177/17085381221141115.
|
| ［13］ |
Saricilar EC, Huang S. Comparison of porcine and human acellular dermal matrix outcomes in wound healing: a deep dive into the evidence［J］. Arch Plast Surg, 2021,48（4）:433⁃439. DOI: 10.5999/aps.2020.02306.
|
| ［14］ |
Kim YH, Shim HS, Lee J, et al. A prospective randomized controlled multicenter clinical trial comparing paste⁃type acellular dermal matrix to standard care for the treatment of chronic wounds［J］. J Clin Med, 2022,11（8）:2203. DOI: 10.3390/jcm11082203.
|
| ［15］ |
Byeon JY, Hwang YS, Choi HJ, et al. A long⁃term follow⁃up study of diabetic foot ulcer using micronized acellular dermal matrix［J］. Int Wound J, 2023,20（5）:1622⁃1637. DOI: 10.1111/iwj.14018.
|
| ［16］ |
Agostinis C, Spazzapan M, Vuerich R, et al. Differential capability of clinically employed dermal regeneration scaffolds to support vascularization for tissue bioengineering［J］. Biomedicines, 2021,9（10）:1458. DOI: 10.3390/biomedicines9101458.
|
| ［17］ |
尹诗璐, 秦泽莲. 真皮替代物在创面和瘢痕修复中的临床应用［J］. 中华皮肤科杂志, 2020,53（6）:476⁃478. DOI: 10.35541/cjd.20190606.
|
| ［18］ |
Holl J, Kowalewski C, Zimek Z, et al. Chronic diabetic wounds and their treatment with skin substitutes［J］. Cells, 2021,10（3）:655. DOI: 10.3390/cells10030655.
|
| ［19］ |
Maacha S, Sidahmed H, Jacob S, et al. Paracrine mechanisms of mesenchymal stromal cells in angiogenesis［J］. Stem Cells Int, 2020,2020:4356359. DOI: 10.1155/2020/4356359.
|
| ［20］ |
Sotnichenko AS, Gilevich IV, Melkonyan KI, et al. Comparative morphological characteristics of the results of implantation of decellularized and recellularized porcine skin scaffolds［J］. Bull Exp Biol Med, 2021,170（3）:378⁃383. DOI: 10.1007/s10517⁃021⁃05071⁃0.
|
| ［21］ |
Monsuur HN, Weijers EM, Gibbs S, et al. Skin substitutes are more potent than dermal or epidermal substitutes in stimulating endothelial cell sprouting［J］. BMC Biomed Eng, 2019,1:18. DOI: 10.1186/s42490⁃019⁃0018⁃8.
|
| ［22］ |
Zimoch J, Zielinska D, Michalak⁃Micka K, et al. Bio⁃engineering a prevascularized human tri⁃layered skin substitute containing a hypodermis［J］. Acta Biomater, 2021,134:215⁃227. DOI: 10.1016/j.actbio.2021.07.033.
|
| ［23］ |
Supp DM, Hahn JM, Lloyd CM, et al. Light or dark pigmentation of engineered skin substitutes containing melanocytes protects against ultraviolet light⁃induced DNA damage in vivo［J］. J Burn Care Res, 2020,41（4）:751⁃760. DOI: 10.1093/jbcr/iraa029.
|
| ［24］ |
Wang J, Wang X, Xie J, et al. Engineered skin substitute regenerates the skin with hair follicle formation［J］. Biomedicines, 2021,9（4）:400. DOI: 10.3390/biomedicines9040400.
|
| ［25］ |
Zhang L, Wang WH, Jin JY, et al. Induction of hair follicle neogenesis with cultured mouse dermal papilla cells in de novo regenerated skin tissues［J］. J Tissue Eng Regen Med, 2019,13（9）:1641⁃1650. DOI: 10.1002/term.2918.
|
| ［26］ |
Varpe A, Sayed M, Mane NS. A comprehensive literature review on advancements and challenges in 3D bioprinting of human organs: ear, skin, and bone［J］. Ann Biomed Eng, 2025,53（1）:14⁃33. DOI: 10.1007/s10439⁃024⁃03580⁃3.
|
| ［27］ |
Sörgel CA, Cai A, Schmid R, et al. Perspectives on the current state of bioprinted skin substitutes for wound healing［J］. Biomedicines, 2023,11（10）:2678. DOI: 10.3390/biomedicines 11102678.
|
| ［28］ |
Balavigneswaran CK, Selvaraj S, Vasudha TK, et al. Tissue engineered skin substitutes: a comprehensive review of basic design, fabrication using 3D printing, recent advances and challenges［J］. Biomater Adv, 2023,153:213570. DOI: 10.1016/j.bioadv.2023.213570.
|
| ［29］ |
Barros NR, Kim HJ, Gouidie MJ, et al. Biofabrication of endothelial cell, dermal fibroblast, and multilayered keratinocyte layers for skin tissue engineering［J］. Biofabrication, 2021,13（3）:035030. DOI: 10.1088/1758⁃5090/aba503.
|
| ［30］ |
Ríos⁃Galacho M, Martínez⁃Moreno D, López⁃Ruiz E, et al. An overview on the manufacturing of functional and mature cellular skin substitutes［J］. Tissue Eng Part B Rev, 2022,28（5）:1035⁃1052. DOI: 10.1089/ten.TEB.2021.0131.
|
| ［31］ |
Baltazar T, Merola J, Catarino C, et al. Three dimensional bioprinting of a vascularized and perfusable skin graft using human keratinocytes, fibroblasts, pericytes, and endothelial cells［J］. Tissue Eng Part A, 2020,26（5⁃6）:227⁃238. DOI: 10.1089/ten.TEA.2019.0201.
|
| ［32］ |
Wei Q, An Y, Zhao X, et al. Three⁃dimensional bioprinting of tissue⁃engineered skin: biomaterials, fabrication techniques, challenging difficulties, and future directions: a review［J］. Int J Biol Macromol, 2024,266（Pt 1）:131281. DOI: 10.1016/j.ijbiomac. 2024.131281.
|
| ［33］ |
Przekora A. A concise review on tissue engineered artificial skin grafts for chronic wound treatment: can we reconstruct functional skin tissue in vitro?［J］. Cells, 2020,9（7）:1622. DOI: 10.3390/cells9071622.
|
| ［34］ |
Boyce ST, Kagan RJ. Composition and performance of autologous engineered skin substitutes for repair or regeneration of excised, full⁃thickness burns［J］. J Burn Care Res, 2023,44（Suppl_1）:S50⁃S56. DOI: 10.1093/jbcr/irac107.
|
